Simple Peptide BPC 157 TB 500 products are research chemicals, not FDA-approved drugs. Learn forms, dosing research, side effects, and how to verify COAs.
Simple Peptide BPC 157 TB 500 is a search term people use when they want to find the BPC-157 and TB-500 listings sold by the online vendor Simple Peptide. That seller markets both compounds as research chemicals for laboratory use, and neither BPC-157 nor TB-500 is FDA-approved for human use in the United States. This guide explains what the two peptides are, how they are sold, and what to check before you place an order.
What BPC-157 and TB-500 Actually Are
BPC-157 is a synthetic 15-amino-acid peptide modeled on a fragment of a protein found in human gastric juice. TB-500 is a synthetic fragment of thymosin beta-4, a protein involved in cell migration and tissue remodeling.
Both compounds have been studied mainly in rodents and other animal models, where researchers have looked at tendon, ligament, muscle, and gut tissue repair. Neither BPC-157 nor TB-500 has completed large randomized controlled human trials, so claims about faster healing or injury recovery remain unproven.
Many people also look into the bpc-157 tb-500 peptide combination because the two are frequently discussed together in recovery and bodybuilding forums.
Why People Search for "Simple Peptide BPC 157 TB 500"
Simple Peptide is one of dozens of online stores that list research peptides. The brand name shows up in searches because buyers want to know whether that specific seller is legitimate, what vial sizes it carries, and whether it offers a combined BPC-157/TB-500 bundle.
Catalogs like this change often. Listings disappear, prices move, and batch numbers rotate, so a review written six months ago may not match what is on the site today.
Two things stay constant across every reputable vendor: the products are labeled "not for human consumption," and each lot should come with a certificate of analysis from an independent lab.
BPC-157 vs TB-500 at a Glance
| Feature | BPC-157 | TB-500 |
|---|---|---|
| Peptide origin | Synthetic fragment derived from a gastric juice protein | Synthetic fragment of thymosin beta-4 |
| Common listed sizes | 5 mg and 10 mg vials | 5 mg and 10 mg vials |
| Main research interest | Tendon, ligament, and gut tissue repair in animal models | Cell migration and soft-tissue remodeling in animal models |
| FDA approval | None for human use | None for human use |
| Compounding status | Not eligible under section 503A | Not eligible under section 503A |
| WADA status | Prohibited in sport | Prohibited in sport |
How These Peptides Are Sold
The format matters as much as the peptide itself. Research-grade material is sold in several physical forms, and each one carries different handling and verification issues.
| Format | Typical listed size | How it is handled | Notes |
|---|---|---|---|
| Lyophilized powder vial | 5 mg or 10 mg | Reconstituted with bacteriostatic water | Most common research format; needs refrigeration |
| Pre-mixed BPC-157/TB-500 blend | 10 mg total | Reconstituted | Ratio varies by vendor; each peptide is harder to verify |
| Capsules | 250-500 mcg per capsule | Swallowed | Human absorption data is minimal |
| Pre-filled syringe or pen | Varies | Injected | Rare; sterility claims need extra scrutiny |
Some sellers also offer bpc-157 tb-500 capsules, which are marketed as a needle-free alternative to reconstituted vials. Capsule products are harder to verify because the powder inside cannot be inspected or weighed by the buyer.
The bpc-157 tb-500 oral vs injection question is one of the most common in peptide communities. Oral delivery avoids needles, but published data on how much of either peptide survives stomach acid and reaches circulation in humans is very limited.
Safety, Side Effects, and Legal Status
BPC-157 and TB-500 are not FDA-approved drugs, and the FDA has placed both on its list of bulk drug substances that are not eligible for compounding under section 503A. Licensed US pharmacies therefore cannot legally compound them for patients.
Reported bpc-157 tb-500 side effects in online user accounts include injection-site pain, redness, headache, nausea, and dizziness. Those reports are anecdotal, and no large trial has systematically tracked adverse events in people.
Because research-grade peptides are not manufactured under pharmaceutical GMP rules, contamination, incorrect concentration, and dosing errors are real risks. Anyone weighing these compounds for a health issue should speak with a licensed healthcare professional first.
TB-500 is banned by the World Anti-Doping Agency, and BPC-157 appears on the same prohibited list, so athletes subject to drug testing should assume a positive result is possible.
How to Vet a Vendor Before Ordering
If you are searching for where to buy bpc-157 and tb-500, treat the certificate of analysis as the deciding factor rather than the lowest price per vial.
- Confirm the COA lists a lot number that matches the vial in the photo.
- Look for HPLC purity results above 98% plus a mass-spec confirmation.
- Check that the testing lab is named and independent of the seller.
- Prefer vendors that ship with cold packs and publish a clear refund policy.
- Avoid any listing that promises healing, weight loss, or specific medical results.
No vendor can honestly guarantee a specific outcome, and a legitimate seller will not describe a research chemical as a treatment. Simple Peptide, like its competitors, operates in a gray area: the compounds are not controlled substances, but they are also not legal to sell as dietary supplements.
The Bottom Line
Simple Peptide BPC 157 TB 500 refers to research chemicals sold for laboratory use, not to an approved therapy. BPC-157 and TB-500 have intriguing animal data but thin human evidence, and their safety profile in people is not well characterized.
If you plan to research them, verify third-party testing, understand the legal limits, and discuss any health decision with a qualified clinician.
Frequently Asked Questions
Is Simple Peptide BPC 157 TB 500 FDA-approved?
No. BPC-157 and TB-500 are not FDA-approved for human use in the United States, and the FDA has placed both on its list of bulk drug substances that cannot be compounded under section 503A. Simple Peptide sells them as research chemicals labeled "not for human consumption," not as medicines or supplements.
What is the difference between BPC-157 and TB-500?
BPC-157 is a synthetic 15-amino-acid peptide based on a fragment of a gastric juice protein, while TB-500 is a synthetic fragment of thymosin beta-4. Researchers study BPC-157 mostly for tendon, ligament, and gut tissue repair, and TB-500 for cell migration and soft-tissue remodeling. Both have far more animal data than human data.
Can you take BPC-157 and TB-500 orally?
Capsule versions exist, but there is little published human data showing how much of either peptide survives digestion and reaches the bloodstream. Most laboratory research uses reconstituted vials rather than oral dosing. Treat oral marketing claims with caution and talk to a healthcare professional before using either compound.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.